Clinical Trial Update: Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

A pilot early-phase 1 trial is investigating whether changes in serum BCMA can indicate disease progression in multiple myeloma and the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Oncotherapeutics | Conditions: Multiple Myeloma | EARLY_Phase 1 | Status: RECRUITING